b3921cfb0740b499…

Study
ID: NCT00065169742 bytesFirst seen Jun 12, 20261 collection

Fields

NameValue
briefSummaryThe purpose of this study is to determine whether the anti-inflammatory drug celecoxib can delay the onset of Alzheimer Disease (AD) in people with Age Associated Memory Impairment (AAMI). This study will also evaluate genetic risk and brain structure as potential predictors of mental decline.
completionDate2005-11
conditions["Alzheimer Disease","Dementia"]
enrollmentCount138
enrollmentTypenull
nctIdNCT00065169
phaseNA
sponsorIduniversity-of-california-los-angeles
startDate2000-11
statusCOMPLETED
studyTypeINTERVENTIONAL
titleAnti-Inflammation in AD: PET Imaging Supplement
urlhttps://clinicaltrials.gov/study/NCT00065169

Canonical JSON

{
  "id": "NCT00065169",
  "type": "Study",
  "data": {
    "briefSummary": "The purpose of this study is to determine whether the anti-inflammatory drug celecoxib can delay the onset of Alzheimer Disease (AD) in people with Age Associated Memory Impairment (AAMI). This study will also evaluate genetic risk and brain structure as potential predictors of mental decline.",
    "completionDate": "2005-11",
    "conditions": [
      "Alzheimer Disease",
      "Dementia"
    ],
    "enrollmentCount": 138,
    "enrollmentType": null,
    "nctId": "NCT00065169",
    "phase": "NA",
    "sponsorId": "university-of-california-los-angeles",
    "startDate": "2000-11",
    "status": "COMPLETED",
    "studyType": "INTERVENTIONAL",
    "title": "Anti-Inflammation in AD: PET Imaging Supplement",
    "url": "https://clinicaltrials.gov/study/NCT00065169"
  }
}

Appears in 1 collection

nih/clinical-trials1 version · Jun 12, 2026

Full hash:b3921cfb0740b499cd5ee436210b6f6c112a3ae2f16a3968ad28cd97eb0c6a00